Pharmasset, Inc. is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. The company’s primary focus is on the development of oral therapeutics for the treatment of hepatitis C virus (“HCV”). Pharmasset currently has two product candidates and a series of preclinical candidates nearing preparation for clinical development.
|Address:||303-A, College Road East, USA, Princeton, NJ, 08540||Website:||Pharmasset, Inc.|
|Phone #:||1-609-6134100||CSR Web Area:||SUBSCRIPTION INFO|